All AbMole products are for research use only, cannot be used for human consumption.
Felbamate(Felbatol) is an anticonvulsant compound used in epilepsy research.
 |
Source | Epilepsy Behav (2017). Figure 4. Felbamate |
| Method | Drug administration | |
| Cell Lines | Sprague–Dawley rats | |
| Concentrations | 3000 mg/rat | |
| Incubation Time | 5 d | |
| Results | In the absence of prior appetitive experience, a quite different pattern emerges, with the FBM-treated rats showing an acquisition deficit that persists throughout much of the training |
 |
Source | Epilepsy Behav (2017). Figure 3. Felbamate |
| Method | Drug administration | |
| Cell Lines | Sprague–Dawley rats | |
| Concentrations | 3000 mg/rat | |
| Incubation Time | 5 d | |
| Results | FBM-treated animals showed enhanced acquisition in the aversive context with prior appetitive training relative to controls |
| Cell Experiment | |
|---|---|
| Cell lines | Follicle cells |
| Preparation method | Drug solutions were diluted into recording MBS from frozen stocks (NMDA, glycine) or dissolved from powder directly into MBS (felbamate, haloperidol) on the day of the experiment. Felbamate was dissolved in MBS to the highest concentration used (up to 3 mM) by heating to 50°C followed by vigorous stirring. The process was repeated once or twice, as necessary, until the felbamate dissolved. |
| Concentrations | 1~3 mM |
| Incubation time | 24 h |
| Animal Experiment | |
|---|---|
| Animal models | |
| Formulation | |
| Dosages | |
| Administration | |
| Molecular Weight | 238.24 |
| Formula | C11H14N2O4 |
| CAS Number | 25451-15-4 |
| Solubility (25°C) | DMSO 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related GluR Products |
|---|
| AZD6765
AZD6765 is an NMDA receptor antagonist. |
| LY404039
LY404039 is a potent, selective and orally active agonist of recombinant human mGlu2, mGlu3 receptors with Ki of 149 nM, 92 nM respectively. |
| CTEP
CTEP (RO4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, shows >1000-fold selectivity over other mGlu receptors. |
| VU 0361737
VU 0361737 is a selective positive allosteric modulator (PAM) for mGlu4 receptor with EC50 of 240 nM and 110 nM at human and rat receptors, respectively. |
| Ampalex
Ampalex is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator which can be used for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
